Saturday 17 October 2026
Export JNJ’s income statement to Excel — free account
Johnson & Johnson
JNJ Healthcare Drug Manufacturers General
Johnson & Johnson’s revenue for fiscal 2025 (year ended December 2025) was $94.2 billion, up 6.05% from fiscal 2024. In the quarter to September 2026, revenue grew 5.86%, EPS was flat, free cash flow grew 154.8% and total debt fell 4.82%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for three, operating cash flow growth for three; insiders bought in the last twelve months.
255.55
2.27
+0.90%
Follow JNJ
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
18.73 | 24.93 | 11.58 | 26.44 | 21.90 | 28.56 | 25.89 | 23.00 | 357.00 | 19.70 |
Piotroski F-Score |
3 | 6 | 6 | 5 | 8 | 4 | 6 | 9 | 4 | 7 |
P/S ratio |
5.29 | 3.92 | 4.76 | 5.85 | 5.72 | 5.02 | 4.70 | 4.24 | 4.90 | 4.41 |
Altman Z-Score |
4.78 | 4.01 | 4.59 | 4.25 | 4.34 | 3.99 | 4.31 | 4.27 | 4.21 | 5.10 |
Altman Z″-Score (non-manufacturers) |
4.71 | 4.41 | 4.69 | 3.67 | 4.21 | 3.69 | 4.08 | 4.43 | 4.09 | 6.39 |
P/FCF ratio |
24.40 | 16.97 | 21.78 | 26.39 | 22.00 | 20.22 | 16.64 | 15.92 | 19.11 | 18.87 |
Beneish M-Score |
(2.26) | (2.75) | (2.71) | (2.65) | (2.54) | (2.79) | (2.69) | (2.68) | (2.80) | (2.51) |
P/Operating CF |
68.16 | 49.86 | 51.54 | 87.44 | 78.55 | 49.66 | 60.31 | 55.42 | 61.39 | 47.66 |
Dividend Safety Score |
78 | — | — | — | — | — | — | — | — | — |
P/B ratio |
6.11 | 4.87 | 5.89 | 6.09 | 6.08 | 6.55 | 6.49 | 5.79 | 6.23 | 4.36 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 206.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.73 |
EV/Sales |
5.49 | 3.99 | 4.79 | 5.91 | 5.70 | 5.11 | 4.79 | 4.34 | 5.06 | 4.14 |
EV/EBITDA |
12.29 | 13.57 | 16.61 | 17.43 | 16.74 | 17.55 | 15.71 | 13.34 | 15.72 | 12.07 |
EV/Operating CF |
21.10 | 14.60 | 17.91 | 22.29 | 19.16 | 17.92 | 16.79 | 15.95 | 18.39 | 15.86 |
EV/FCF |
25.35 | 17.27 | 21.94 | 26.65 | 21.92 | 20.58 | 16.95 | 16.29 | 19.75 | 17.71 |
Quick Ratio |
0.69 | 0.78 | 0.82 | 0.65 | 1.04 | 0.91 | 0.94 | 1.08 | 1.04 | 2.04 |
Current Ratio |
1.03 | 1.11 | 1.16 | 0.99 | 1.35 | 1.21 | 1.26 | 1.47 | 1.41 | 2.47 |
Net Debt/EBITDA |
0.46 | 0.23 | 0.12 | 0.17 | (0.06) | 0.31 | 0.29 | 0.30 | 0.50 | (0.79) |
Debt/Assets |
19.80% | 17.02% | 15.45% | 14.35% | 16.47% | 18.66% | 16.80% | 18.10% | 19.50% | 15.89% |
Debt/Equity |
0.48 | 0.43 | 0.38 | 0.35 | 0.41 | 0.52 | 0.45 | 0.46 | 0.51 | 0.32 |
Asset Turnover |
0.50 | 0.51 | 0.48 | 0.43 | 0.44 | 0.50 | 0.53 | 0.53 | 0.51 | 0.52 |
Operating CF/Net income |
0.92 | 1.73 | 0.65 | 1.18 | 1.12 | 1.60 | 1.55 | 1.45 | 16.20 | 1.13 |
Capex/Depreciation |
(0.55) | (0.51) | (0.56) | (0.50) | (0.40) | (0.42) | (0.03) | (0.07) | (0.26) | (0.52) |
Interest Coverage |
35.64 | 24.87 | 22.14 | 72.92 | 106.09 | 83.63 | 56.61 | 19.52 | 20.33 | 28.78 |
| 35.03% | 20.06% | 48.29% | 23.79% | 30.41% | 23.97% | 25.36% | 25.51% | 1.99% | 23.60% | |
| 14.13% | 8.09% | 19.81% | 9.71% | 11.70% | 8.85% | 9.73% | 9.86% | 0.87% | 12.05% | |
ROIC |
20.19% | 13.44% | 13.12% | 14.86% | 16.56% | 14.58% | 16.24% | 16.60% | 15.23% | 24.29% |
Return on Tangible Assets |
108.66% | 53.91% | 129.66% | 102.67% | 60.14% | 53.49% | 56.06% | 48.05% | 4.40% | 30.26% |
Average Days of Receivables |
66.57 | 60.99 | 63.75 | 64.06 | 70.84 | 60.00 | 64.41 | 63.08 | 64.41 | 59.40 |
Research and Development Expense of Revenue |
15.57% | 19.40% | 17.71% | 17.67% | 18.13% | 14.72% | 13.84% | 13.21% | 13.86% | 12.72% |
Selling, General and Administrative Expense of Revenue |
25.14% | 25.75% | 25.26% | 25.31% | 25.55% | 26.74% | 27.03% | 27.63% | 28.15% | 27.91% |
Intangible Assets out of Total Assets |
0.50 | 0.45 | 0.42 | 0.40 | 0.45 | 0.51 | 0.52 | 0.51 | 0.54 | 0.35 |
Share Based Compensation of Revenue |
1.44% | 1.32% | 1.36% | 1.42% | 1.44% | 1.22% | 1.19% | 1.20% | 1.26% | 1.22% |
Graham Net Nets |
(0.12) | (0.15) | (0.11) | (0.12) | (0.10) | (0.15) | (0.14) | (0.14) | (0.14) | (0.02) |
Graham Number |
91.77 | 62.26 | 91.84 | 66.61 | 70.30 | 54.59 | 53.39 | 53.03 | 14.00 | 0.00 |
Earnings Yield |
5.34% | 4.01% | 8.63% | 3.78% | 4.57% | 3.50% | 3.86% | 4.35% | 0.28% | 5.08% |
Free Cash Flow Yield |
4.10% | 5.89% | 4.59% | 3.79% | 4.55% | 4.95% | 6.01% | 6.28% | 5.23% | 5.30% |
Revenue per Share |
39.13 | 36.90 | 33.61 | 30.47 | 29.92 | 31.37 | 31.02 | 30.42 | 28.40 | 26.26 |
Operating CF per Share |
10.19 | 10.08 | 9.00 | 8.07 | 8.89 | 8.94 | 8.85 | 8.28 | 7.82 | 6.86 |
Capex per Share |
(1.71) | (1.56) | (1.65) | (1.32) | (1.12) | (1.16) | (0.09) | (0.17) | (0.54) | (0.72) |
Free Cash Flow per Share |
8.48 | 8.52 | 7.34 | 6.75 | 7.78 | 7.78 | 8.76 | 8.11 | 7.28 | 6.14 |
Cash per Share |
8.35 | 10.19 | 9.05 | 8.49 | 12.01 | 9.57 | 7.29 | 7.34 | 6.80 | 15.31 |
Shareholders Equity per Share |
33.87 | 29.70 | 27.15 | 29.26 | 28.12 | 24.03 | 22.48 | 22.28 | 22.35 | 25.73 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
33.87 | 29.70 | 27.15 | 29.26 | 28.12 | 24.03 | 22.48 | 22.28 | 22.35 | 25.73 |
Free Cash Flow |
20,418.00 | 20,517.00 | 18,606.00 | 17,728.00 | 20,469.00 | 20,494.00 | 23,183.00 | 21,734.00 | 19,609.00 | 16,808.00 |
Working Capital |
1,498.00 | 5,572.00 | 7,213.00 | (508.00) | 15,753.00 | 8,744.00 | 9,310.00 | 14,803.00 | 12,551.00 | 38,745.00 |
Capital Expenditures |
(4,112.00) | (3,749.00) | (4,185.00) | (3,466.00) | (2,941.00) | (3,042.00) | (233.00) | (467.00) | (1,447.00) | (1,959.00) |
Net Current Asset Value |
(62,042.00) | (52,721.00) | (45,289.00) | (55,280.00) | (47,016.00) | (60,379.00) | (52,983.00) | (47,169.00) | (54,055.00) | (5,758.00) |
EV/EBIT |
14.95 | 18.87 | 23.88 | 23.47 | 23.11 | 25.09 | 21.83 | 18.05 | 20.39 | 14.24 |
Capex to Sales |
0.04 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.00 | 0.01 | 0.02 | 0.03 |
Price to Operating Income |
15.29 | 20.86 | 26.91 | 24.16 | 23.48 | 25.12 | 22.27 | 19.23 | 21.21 | 16.01 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.32 | 0.36 | 0.38 | 0.39 | 0.39 | 0.39 | 0.40 | 0.41 | 0.33 | 0.24 |
Cash ROIC |
14.47% | 16.20% | 15.82% | 14.07% | 15.09% | 16.92% | 22.03% | 20.29% | 17.97% | 12.47% |
Accounts Receivable Turnover |
5.88 | 5.98 | 5.89 | 5.46 | 5.46 | 5.89 | 5.74 | 5.91 | 6.07 | 6.41 |
Accounts Payable Turnover |
2.71 | 2.76 | 2.72 | 2.35 | 2.28 | 3.15 | 3.43 | 3.65 | 3.58 | 3.21 |
Inventory Turnover |
2.27 | 2.33 | 2.48 | 2.38 | 2.37 | 3.10 | 3.13 | 3.12 | 3.01 | 2.69 |
Average Days of Payables |
144.66 | 137.00 | 132.40 | 146.75 | 172.42 | 122.04 | 113.17 | 101.55 | 104.88 | 115.89 |
Days of Inventory on Hand |
171.20 | 165.34 | 153.70 | 152.38 | 162.01 | 119.98 | 119.48 | 115.86 | 125.76 | 136.42 |
Average Receivables |
16,010.00 | 14,857.50 | 14,456.00 | 14,661.00 | 14,429.50 | 14,028.50 | 14,289.50 | 13,794.00 | 12,594.50 | 11,216.50 |
Average Payables |
11,151.00 | 9,971.50 | 9,760.50 | 10,472.00 | 10,280.00 | 9,024.50 | 8,040.50 | 7,423.50 | 7,114.00 | 6,793.00 |
Average Inventory |
13,317.50 | 11,812.50 | 10,724.50 | 10,327.50 | 9,865.50 | 9,182.00 | 8,809.50 | 8,682.00 | 8,454.50 | 8,098.50 |
Average Assets |
189,657.00 | 173,831.00 | 177,468.00 | 184,698.00 | 178,456.00 | 166,311.00 | 155,341.00 | 155,128.50 | 149,255.50 | 137,309.50 |
Average Common Equity |
76,517.00 | 70,132.00 | 72,789.00 | 75,413.50 | 68,650.50 | 61,374.50 | 59,611.50 | 59,956.00 | 65,289.00 | 70,085.00 |
Columns are period end dates · fundamentals updated 14 Oct 2026